Leveraging FibroScan® Solutions for Optimized Management of Patients with Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Wednesday, September 20th
from 12 PM to 1 PM ET (USA)
from 6 PM to 7 PM CET (Europe)
Join this webinar exploring the management of patients with obesity and MASLD and the application of elastography in both bariatric and metabolic interventions.
Learn from renowned experts, dive into understanding the burden of obesity and MASLD, and discover how VCTE™ (FibroScan®) can enhance treatment decisions for better patient outcomes. Don\’t miss this opportunity to elevate your knowledge in MASLD management and its intersection with bariatric and metabolic surgery.